About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
When the government steps in between patients and their doctor to decide the value or price of a treatment, patient access suffers. That’s exactly what is predicted to happen to Part D medicines affected by the Inflation Reduction Act’s (IRA’s) flawed new price-setting program – both those directly price-set and also other therapeutic competitors within the same class.
How the IRA’s Drug Price-Setting Program Threatens Seniors’ Access to Medicines image
Report
Government Price Setting
How the IRA’s Drug Price-Setting Program Threatens Seniors’ Access to Medicines
How the IRA’s Drug Price-Setting Program Threatens Seniors’ Access to Medicines image